Gain of function in the immune system caused by a ryanodine receptor 1 mutation

Journal of Cell Science

Volumn 126, Issue 15, 2013, Pages 3485-3492

  Vukcevic, Mirko ^a   Zorzato, Francesco ^a,b   Keck, Simone ^a   Tsakiris, Dimitrios A ^a   Keiser, Jennifer ^c   Maizels, Rick M ^d   Treves, Susan ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF FERRARA   (Italy)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Dendritic cell; Immune system; Ryanodine receptor; RyR1

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; RYANODINE RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DENDRITIC CELL; GAIN OF FUNCTION MUTATION; HETEROZYGOTE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; KNOCK IN MOUSE; LYMPHOCYTE PROLIFERATION; MALE; MALIGNANT HYPERTHERMIA; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WILD TYPE;

DENDRITIC CELL; IMMUNE SYSTEM; RYANODINE RECEPTOR; RYR1;

ANIMALS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; IMMUNOGLOBULINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NEMATOSPIROIDES DUBIUS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; STRONGYLIDA INFECTIONS;

EID: 84883579204     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.130310     Document Type: Article

References (32)

1. Avrameas, S., Ternynck, T., Tsonis, I. A. and Lymberi, P. (2007). Naturally occurring B-cell autoreactivity: a critical overview. J. Autoimmun. 29, 213-218.
2. Baeuerle, P. A. and Henkel, T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
3. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
4. Baumgarth, N., Tung, J. W. and Herzenberg, L. A. (2005). Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 26, 347-362.
5. Berchtold, S., Ogilvie, A. L., Bogdan, C., Mühl-Zürbes, P., Ogilvie, A., Schuler, G. and Steinkasserer, A. (1999). Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett. 458, 424-428.
6. Bracci, L., Vukcevic, M., Spagnoli, G., Ducreux, S., Zorzato, F. and Treves, S. (2007). Ca2+ signaling through ryanodine receptor 1 enhances maturation and activation of human dendritic cells. J. Cell Sci. 120, 2232-2240.
7. Chelu, M. G., Goonasekera, S. A., Durham, W. J., Tang, W., Lueck, J. D., Riehl, J., Pessah, I. N., Zhang, P., Bhattacharjee, M. B., Dirksen, R. T. et al. (2006). Heat-and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J. 20, 329-330.
8. Clay, C. A., Lehmer, E. M., Jeor, S. S. and Dearing, M. D. (2009). Sin nombre virus and rodent species diversity: a test of the dilution and amplification hypotheses. PLoS ONE 4, e6467.
9. De Crescenzo, V., Fogarty, K. E., Lefkowitz, J. J., Bellve, K. D., Zvaritch, E., MacLennan, D. H. and Walsh, J. V., Jr (2012). Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype. Proc. Natl. Acad. Sci. USA 109, 610-615.
10. Ducreux, S., Zorzato, F., Müller, C., Sewry, C., Muntoni, F., Quinlivan, R., Restagno, G., Girard, T. and Treves, S. (2004). Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J. Biol. Chem. 279, 43838-43846.
11. Frantz, B., Nordby, E. C., Bren, G., Steffan, N., Paya, C. V., Kincaid, R. L., Tocci, M. J., O'Keefe, S. J. and O'Neill, E. A. (1994). Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. EMBO J. 13, 861-870.
12. Girard, T., Cavagna, D., Padovan, E., Spagnoli, G., Urwyler, A., Zorzato, F. and Treves, S. (2001). B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators. J. Biol. Chem. 276, 48077-48082.
13. Hewitson, J. P., Harcus, Y., Murray, J., van Agtmaal, M., Filbey, K. J., Grainger, J. R., Bridgett, S., Blaxter, M. L., Ashton, P. D., Ashford, D. A. et al. (2011). Proteomic analysis of secretory products from the model gastrointestinal nematode Heligmosomoides polygyrus reveals dominance of venom allergen-like (VAL) proteins. J. Proteomics 74, 1573-1594.
14. Klein, E., Koch, S., Borm, B., Neumann, J., Herzog, V., Koch, N. and Bieber, T. (2005). CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. Int. Immunol. 17, 477-487.
15. Kuwano, Y., Prazma, C. M., Yazawa, N., Watanabe, R., Ishiura, N., Kumanogoh, A., Okochi, H., Tamaki, K., Fujimoto, M. and Tedder, T. F. (2007). CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. Int. Immunol. 19, 977-992.
16. Levano, S., Vukcevic, M., Singer, M., Matter, A., Treves, S., Urwyler, A. and Girard, T. (2009). Increasing the number of diagnostic mutations in malignant hyperthermia. Hum. Mutat. 30, 590-598.
17. López, J. R., Linares, N., Pessah, I. N. and Allen, P. D. (2005). Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i. Am. J. Physiol. Cell Physiol. 288, C606-C612.
18. McCoy, K. D., Harris, N. L., Diener, P., Hatak, S., Odermatt, B., Hangartner, L., Senn, B. M., Marsland, B. J., Geuking, M. B., Hengartner, H. et al. (2006). Natural IgE production in the absence of MHC Class II cognate help. Immunity 24, 329-339.
19. O'Connell, P. J., Klyachko, V. A. and Ahern, G. P. (2002). Identification of functional type 1 ryanodine receptors in mouse dendritic cells. FEBS Lett. 512, 67-70.
20. Ochsenbein, A. F., Fehr, T., Lutz, C., Suter, M., Brombacher, F., Hengartner, H. and Zinkernagel, R. M. (1999). Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156-2159.
21. Robinson, R., Carpenter, D., Shaw, M. A., Halsall, J. and Hopkins, P. (2006). Mutations in RYR1 in malignant hyperthermia and central core disease. Hum. Mutat. 27, 977-989.
22. Sei, Y., Gallagher, K. L. and Basile, A. S. (1999). Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes. J. Biol. Chem. 274, 5995-6002.
23. Stolk, M., Leon-Ponte, M., Merrill, M., Ahern, G. P. and O'Connell, P. J. (2006). IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. J. Leukoc. Biol. 80, 651-658.
24. Treves, S., Jungbluth, H., Muntoni, F. and Zorzato, F. (2008). Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr. Opin. Pharmacol. 8, 319-326.
25. Uemura, Y., Liu, T. Y., Narita, Y., Suzuki, M., Ohshima, S., Mizukami, S., Ichihara, Y., Kikuchi, H. and Matsushita, S. (2007). Identification of functional type 1 ryanodine receptors in human dendritic cells. Biochem. Biophys. Res. Commun. 362, 510-515.
26. Vukcevic, M., Spagnoli, G. C., Iezzi, G., Zorzato, F. and Treves, S. (2008). Ryanodine receptor activation by Ca v 1.2 is involved in dendritic cell major histocompatibility complex class II surface expression. J. Biol. Chem. 283, 34913-34922.
27. Vukcevic, M., Broman, M., Islander, G., Bodelsson, M., Ranklev-Twetman, E., Müller, C. R. and Treves, S. (2010). Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease. Anesth. Analg. 111, 185-190.
28. Weissman, D., Li, Y., Ananworanich, J., Zhou, L. J., Adelsberger, J., Tedder, T. F., Baseler, M. and Fauci, A. S. (1995). Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92, 826-830.
29. Withers, D. R., Jaensson, E., Gaspal, F., McConnell, F. M., Eksteen, B., Anderson, G., Agace, W. W. and Lane, P. J. (2009). The survival of memory CD4+ T cells within the gut lamina propria requires OX40 and CD30 signals. J. Immunol. 183, 5079-5084.
30. Yazdanbakhsh, M., Kremsner, P. G. and van Ree, R. (2002). Allergy, parasites, and the hygiene hypothesis. Science 296, 490-494.
31. Zhou, L. J. and Tedder, T. F. (1996). CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93, 2588-2592.
32. Zhu, J., Yamane, H. and Paul, W. E. (2010). Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28, 445-489.